XRTX Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue RD Costs Shares Climb Catalyst Pharmaceuticals Inc CPRX Q1 2026 Earnings EPS Beats Estimates by 75 Stock Edges Slightly Lower Parsons Corporation PSN Q1 2026 Earnings EPS Surges Past Estimates as Operational Execution Drives Performance Eton Pharmaceuticals Q1 2026 Earnings EPS Miss Triggers Stock Decline Alamo Group Q1 2026 Earnings Strong EPS Beat Amid Steady Operational Execution RNAC Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline